Radhika Rajan
Overview
Explore the profile of Radhika Rajan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
936
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dias R, Rajan R, Baeta M, Belbut B, Marques T, Petreanu L
Neuron
. 2024 Aug;
112(19):3329-3342.e7.
PMID: 39137776
The role of experience in the organization of cortical feedback (FB) remains unknown. We measured the effects of manipulating visual experience on the retinotopic specificity of supragranular and infragranular projections...
2.
Lazar L, Chand P, Rajan R, Mohammed H, Jain N
Cereb Cortex
. 2022 Feb;
33(1):195-206.
PMID: 35226918
The evolution of opposable thumb has enabled fine grasping ability and precision grip, therefore the ability to finely manipulate the objects and refined tool use. Since tactile inputs to an...
3.
Kambi N, Halder P, Rajan R, Arora V, Chand P, Arora M, et al.
Nat Commun
. 2014 Apr;
5:3602.
PMID: 24710038
Adult mammalian brains undergo reorganization following deafferentations due to peripheral nerve, cortical or spinal cord injuries. The largest extent of cortical reorganization is seen in area 3b of the somatosensory...
4.
5.
Fraser Symmans W, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, et al.
J Clin Oncol
. 2007 Sep;
25(28):4414-22.
PMID: 17785706
Purpose: To measure residual disease after neoadjuvant chemotherapy in order to improve the prognostic information that can be obtained from evaluating pathologic response. Patients And Methods: Pathologic slides and reports...
6.
Rouzier R, Rajan R, Wagner P, Hess K, Gold D, Stec J, et al.
Proc Natl Acad Sci U S A
. 2005 May;
102(23):8315-20.
PMID: 15914550
Breast cancers show variable sensitivity to paclitaxel. There is no diagnostic test to identify tumors that are sensitive to this drug. We used U133A chips to identify genes that are...
7.
Rajan R, Esteva F, Fraser Symmans W
Clin Breast Cancer
. 2004 Sep;
5(3):235-8.
PMID: 15335458
Neoadjuvant chemotherapy (also known as preoperative or primary chemotherapy) is the treatment of choice for patients with locally advanced breast cancer. One of the main advantages of neoadjuvant chemotherapy is...
8.
Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors
Rouzier R, Mathieu M, Sideris L, Youmsi E, Rajan R, Garbay J, et al.
Cancer
. 2004 Aug;
101(5):918-25.
PMID: 15329898
Background: Randomized trials comparing neoadjuvant versus adjuvant chemotherapy show that primary chemotherapy allows more frequent breast-preserving surgery even though no survival advantage has been demonstrated. The aim of the current...
9.
Rajan R, Poniecka A, Smith T, Yang Y, Frye D, Pusztai L, et al.
Cancer
. 2004 Mar;
100(7):1365-73.
PMID: 15042669
Background: Complete pathologic response of breast carcinoma to neoadjuvant chemotherapy is a well defined outcome that correlates with prolonged survival. Categorization of incomplete response depends on accurate measurement of residual...